Even as U.S. Attorney General Jeff Sessions continues to say terrible things about marijuana and hint at a potential crackdown against states that have approved recreational or medical sales, assorted members of Congress have introduced legislation aimed at changing the way the federal government deals with the plant, including its designation as a Schedule I narcotic by the Drug Enforcement Administration. But there’s disagreement among national leaders of the cannabis community about whether it would be preferable to shift marijuana to Schedule II or Schedule III, or to de-schedule it entirely.
HR 714, sponsored by Representative H. Morgan Griffith, a Virginia Republican, and introduced in January, would move marijuana from Schedule I, which includes heroin and acknowledges no medical benefit, to Schedule II alongside cocaine, opium and other substances that can be used medically. Another Griffith bill, HR 715, calls for marijuana to be switched from Schedule I to another DEA classification, but doesn’t specify which one. And in April, Representative Matt Gaetz, a Republican from Florida, put forward HR 2020, which would place marijuana in Schedule III, where assorted stimulants (e.g., benzphetamine), depressants (amobarbital) and products such as Tylenol with codeine are listed.
Still, these legislative efforts fall short in the view of Justin Strekal, political director for the National Organization for the Reform of Marijuana Laws (NORML).
Information source: westword.com